

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.52558727 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.12234082 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.12234082 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.47831129 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.31477501 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.21554517 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.21554517 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.21554517 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.21554517 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.21554517 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 5.21554517 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 5.09711153 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.04562253 |
| 14 | detection of bacterium (GO:0016045) | 5.01575419 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.99619957 |
| 16 | detection of other organism (GO:0098543) | 4.98214381 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.71384374 |
| 18 | negative T cell selection (GO:0043383) | 4.57965435 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.52427832 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.48730954 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.41634136 |
| 22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.38202133 |
| 23 | positive thymic T cell selection (GO:0045059) | 4.35045459 |
| 24 | response to interleukin-15 (GO:0070672) | 4.34947128 |
| 25 | viral transcription (GO:0019083) | 4.32224027 |
| 26 | T cell migration (GO:0072678) | 4.29690257 |
| 27 | leukocyte aggregation (GO:0070486) | 4.28110922 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 4.27434989 |
| 29 | respiratory burst (GO:0045730) | 4.18634680 |
| 30 | translational termination (GO:0006415) | 4.09470284 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 4.08536158 |
| 32 | B cell receptor signaling pathway (GO:0050853) | 4.02382945 |
| 33 | interferon-gamma production (GO:0032609) | 4.02116952 |
| 34 | response to peptidoglycan (GO:0032494) | 3.99541653 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.98732237 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.93353834 |
| 37 | neutrophil activation (GO:0042119) | 3.92873079 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.88005385 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.87482393 |
| 40 | thymic T cell selection (GO:0045061) | 3.86193813 |
| 41 | cellular extravasation (GO:0045123) | 3.84707534 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.82537241 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.81175055 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.79597511 |
| 45 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.79591729 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.77045300 |
| 47 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.76473358 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75835980 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.75835980 |
| 50 | positive T cell selection (GO:0043368) | 3.75806276 |
| 51 | DNA deamination (GO:0045006) | 3.71589004 |
| 52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70270943 |
| 53 | T cell selection (GO:0045058) | 3.69046152 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.65485757 |
| 55 | response to host immune response (GO:0052572) | 3.65485757 |
| 56 | T cell homeostasis (GO:0043029) | 3.63077407 |
| 57 | translational elongation (GO:0006414) | 3.62504344 |
| 58 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.62488275 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.61372885 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.58667709 |
| 61 | ribosomal small subunit biogenesis (GO:0042274) | 3.58179423 |
| 62 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.57355659 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 3.56991496 |
| 64 | mast cell activation (GO:0045576) | 3.56758518 |
| 65 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.54623304 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.54491690 |
| 67 | granulocyte activation (GO:0036230) | 3.52688169 |
| 68 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.52286432 |
| 69 | T cell receptor signaling pathway (GO:0050852) | 3.48498190 |
| 70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48101681 |
| 71 | cotranslational protein targeting to membrane (GO:0006613) | 3.41691362 |
| 72 | protein targeting to ER (GO:0045047) | 3.41095768 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.40345110 |
| 74 | response to host (GO:0075136) | 3.38260825 |
| 75 | response to host defenses (GO:0052200) | 3.38260825 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.38260825 |
| 77 | B cell mediated immunity (GO:0019724) | 3.35146396 |
| 78 | regulation of tolerance induction (GO:0002643) | 3.34088262 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.33384983 |
| 80 | leukocyte degranulation (GO:0043299) | 3.32946962 |
| 81 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.32036148 |
| 82 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.31015090 |
| 83 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.31015090 |
| 84 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30351895 |
| 85 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.29554580 |
| 86 | T cell costimulation (GO:0031295) | 3.28278111 |
| 87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28154595 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 3.27542430 |
| 89 | microglial cell activation (GO:0001774) | 3.27364164 |
| 90 | lymphocyte costimulation (GO:0031294) | 3.27262776 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27022579 |
| 92 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.26102531 |
| 93 | negative regulation of phagocytosis (GO:0050765) | 3.24519406 |
| 94 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.23225009 |
| 95 | protein localization to endoplasmic reticulum (GO:0070972) | 3.23075956 |
| 96 | positive regulation of isotype switching (GO:0045830) | 3.20902607 |
| 97 | viral life cycle (GO:0019058) | 3.19793618 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18861796 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18828943 |
| 100 | tolerance induction (GO:0002507) | 3.18213198 |
| 101 | activated T cell proliferation (GO:0050798) | 3.17573459 |
| 102 | neutrophil mediated immunity (GO:0002446) | 3.15793102 |
| 103 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15561663 |
| 104 | maturation of SSU-rRNA (GO:0030490) | 3.15416805 |
| 105 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15043911 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15043911 |
| 107 | positive regulation of mast cell activation (GO:0033005) | 3.14463453 |
| 108 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.12816526 |
| 109 | mast cell degranulation (GO:0043303) | 3.12143731 |
| 110 | mast cell activation involved in immune response (GO:0002279) | 3.12143731 |
| 111 | response to muramyl dipeptide (GO:0032495) | 3.11329821 |
| 112 | lymphocyte homeostasis (GO:0002260) | 3.11074696 |
| 113 | regulation of leukocyte degranulation (GO:0043300) | 3.10776908 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 3.10408156 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09260703 |
| 116 | regulation of mast cell activation (GO:0033003) | 3.08941082 |
| 117 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.08898150 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 3.08488773 |
| 119 | cellular protein complex disassembly (GO:0043624) | 3.07664092 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.07173837 |
| 121 | negative regulation of innate immune response (GO:0045824) | 3.04847706 |
| 122 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04418218 |
| 123 | megakaryocyte development (GO:0035855) | 3.03940700 |
| 124 | macrophage activation (GO:0042116) | 3.01272229 |
| 125 | response to type I interferon (GO:0034340) | 3.00251850 |
| 126 | response to protozoan (GO:0001562) | 2.98791761 |
| 127 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96824322 |
| 128 | natural killer cell activation (GO:0030101) | 2.96674688 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.96643193 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.96643193 |
| 131 | regulation of regulatory T cell differentiation (GO:0045589) | 2.95617604 |
| 132 | definitive hemopoiesis (GO:0060216) | 2.92234626 |
| 133 | NIK/NF-kappaB signaling (GO:0038061) | 2.92076865 |
| 134 | lymph node development (GO:0048535) | 2.90129123 |
| 135 | leukocyte homeostasis (GO:0001776) | 2.88948719 |
| 136 | defense response to protozoan (GO:0042832) | 2.88921297 |
| 137 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87419254 |
| 138 | mature B cell differentiation (GO:0002335) | 2.86054052 |
| 139 | regulation of isotype switching (GO:0045191) | 2.85928217 |
| 140 | translational initiation (GO:0006413) | 2.85235084 |
| 141 | positive regulation of DNA recombination (GO:0045911) | 2.83932648 |
| 142 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.83098008 |
| 143 | regulation of B cell mediated immunity (GO:0002712) | 2.82729351 |
| 144 | regulation of response to interferon-gamma (GO:0060330) | 2.81161391 |
| 145 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.80779389 |
| 146 | positive regulation of interleukin-2 production (GO:0032743) | 2.79900592 |
| 147 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.79149996 |
| 148 | protein complex disassembly (GO:0043241) | 2.77815244 |
| 149 | cellular response to zinc ion (GO:0071294) | 2.76677796 |
| 150 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.76242209 |
| 151 | positive regulation of B cell mediated immunity (GO:0002714) | 2.75749028 |
| 152 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.75749028 |
| 153 | natural killer cell differentiation (GO:0001779) | 2.73642069 |
| 154 | myeloid dendritic cell activation (GO:0001773) | 2.73130839 |
| 155 | sequestering of actin monomers (GO:0042989) | 2.72835570 |
| 156 | immunoglobulin mediated immune response (GO:0016064) | 2.72638057 |
| 157 | leukocyte cell-cell adhesion (GO:0007159) | 2.72353182 |
| 158 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72339461 |
| 159 | T cell differentiation (GO:0030217) | 2.70608075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.75751876 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.93805104 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88789853 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.87803173 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.43275553 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 3.38096928 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31084463 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.99668943 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.92398774 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.88171057 |
| 11 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71949628 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65367923 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61304338 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60813193 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.57949044 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.53880331 |
| 17 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.43401517 |
| 18 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.40468831 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.39918795 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.36552038 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.36510667 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34867939 |
| 23 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33325517 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.27952366 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.25210822 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25122723 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 2.22630068 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20514840 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07050107 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02615154 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02044674 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.00219907 |
| 33 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99215891 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93630387 |
| 35 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90870247 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.86844050 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84832854 |
| 38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.82011258 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.80253521 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79027449 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77577331 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77198393 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74919370 |
| 44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73807898 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.72891810 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70752796 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69981528 |
| 48 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68449124 |
| 49 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66528207 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65960487 |
| 51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63434960 |
| 52 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.56156804 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55737765 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55009963 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.54500760 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53785182 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.48713857 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47599013 |
| 59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.45466693 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43993996 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42825394 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42566307 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41195624 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41139409 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39204158 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38487452 |
| 67 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38023735 |
| 68 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35003573 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34165899 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34086103 |
| 71 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.33964493 |
| 72 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.32866913 |
| 73 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30883425 |
| 74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.30817433 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29666544 |
| 76 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29608072 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29377594 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29038462 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25797488 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25712746 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24723381 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24261169 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23786101 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23597885 |
| 85 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23146134 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22504105 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21730482 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21538983 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20117656 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18988173 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17864292 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17797924 |
| 93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.17778113 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.17370122 |
| 95 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15898712 |
| 96 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14664812 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12413967 |
| 98 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11021771 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11016455 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09472628 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07499831 |
| 102 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07378697 |
| 103 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07056574 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06480704 |
| 105 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05185471 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04967939 |
| 107 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03614665 |
| 108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03369172 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02794425 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02658203 |
| 111 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02222795 |
| 112 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01790537 |
| 113 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00351781 |
| 114 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99641337 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99553044 |
| 116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98614450 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97867354 |
| 118 | P68_20966046_ChIP-Seq_HELA_Human | 0.97798440 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97726209 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97493298 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95305787 |
| 122 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95203326 |
| 123 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94938993 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93948027 |
| 125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93931884 |
| 126 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.92758287 |
| 127 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92437199 |
| 128 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91692958 |
| 129 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.90890199 |
| 130 | P300_27268052_Chip-Seq_Bcells_Human | 0.90815273 |
| 131 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.89050520 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87269844 |
| 133 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86397124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.14040313 |
| 2 | MP0005671_abnormal_response_to | 3.85498823 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.84986976 |
| 4 | MP0000685_abnormal_immune_system | 3.54794587 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.38722646 |
| 6 | MP0001800_abnormal_humoral_immune | 3.30418995 |
| 7 | MP0009785_altered_susceptibility_to | 3.01651567 |
| 8 | MP0001790_abnormal_immune_system | 2.97379401 |
| 9 | MP0005387_immune_system_phenotype | 2.97379401 |
| 10 | MP0002398_abnormal_bone_marrow | 2.92133356 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.86126191 |
| 12 | MP0001819_abnormal_immune_cell | 2.81662142 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.79468747 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.78662826 |
| 15 | MP0002723_abnormal_immune_serum | 2.77748622 |
| 16 | MP0005025_abnormal_response_to | 2.61222889 |
| 17 | MP0000716_abnormal_immune_system | 2.50561936 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.49563021 |
| 19 | MP0003436_decreased_susceptibility_to | 2.41409676 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.39139148 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.35738208 |
| 22 | MP0002722_abnormal_immune_system | 2.35334094 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 2.26060565 |
| 24 | MP0003724_increased_susceptibility_to | 2.25817543 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.24773901 |
| 26 | MP0000703_abnormal_thymus_morphology | 2.21330489 |
| 27 | MP0002405_respiratory_system_inflammati | 2.17706780 |
| 28 | MP0002429_abnormal_blood_cell | 2.17299744 |
| 29 | MP0002419_abnormal_innate_immunity | 2.11775428 |
| 30 | MP0001873_stomach_inflammation | 2.11305064 |
| 31 | MP0010155_abnormal_intestine_physiology | 2.09151929 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.02626950 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.99092422 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.99092422 |
| 35 | MP0003866_abnormal_defecation | 1.92568887 |
| 36 | MP0002006_tumorigenesis | 1.89681838 |
| 37 | MP0001853_heart_inflammation | 1.77485197 |
| 38 | MP0000490_abnormal_crypts_of | 1.74555808 |
| 39 | MP0003303_peritoneal_inflammation | 1.72291651 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.70260662 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.68404051 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.67597656 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.66503667 |
| 44 | MP0006082_CNS_inflammation | 1.66132832 |
| 45 | MP0002933_joint_inflammation | 1.57702334 |
| 46 | MP0008260_abnormal_autophagy | 1.56262855 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.55097498 |
| 48 | MP0002132_abnormal_respiratory_system | 1.54434919 |
| 49 | MP0004947_skin_inflammation | 1.47632559 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.39151554 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.39134988 |
| 52 | MP0000858_altered_metastatic_potential | 1.38781606 |
| 53 | MP0009278_abnormal_bone_marrow | 1.32260415 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.31653167 |
| 55 | MP0008057_abnormal_DNA_replication | 1.30044551 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.29674598 |
| 57 | MP0005451_abnormal_body_composition | 1.28754145 |
| 58 | MP0003077_abnormal_cell_cycle | 1.25301253 |
| 59 | MP0008469_abnormal_protein_level | 1.22263389 |
| 60 | MP0005310_abnormal_salivary_gland | 1.20728760 |
| 61 | MP0010094_abnormal_chromosome_stability | 1.20489880 |
| 62 | MP0002095_abnormal_skin_pigmentation | 1.19935457 |
| 63 | MP0008058_abnormal_DNA_repair | 1.11015973 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.07563819 |
| 65 | MP0008007_abnormal_cellular_replicative | 1.06697336 |
| 66 | MP0004883_abnormal_blood_vessel | 1.06557344 |
| 67 | MP0006054_spinal_hemorrhage | 1.05172130 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.03949429 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.00153264 |
| 70 | MP0003111_abnormal_nucleus_morphology | 0.97843234 |
| 71 | MP0004510_myositis | 0.97724467 |
| 72 | MP0003075_altered_response_to | 0.94538509 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 0.94031567 |
| 74 | MP0005166_decreased_susceptibility_to | 0.93520851 |
| 75 | MP0003448_altered_tumor_morphology | 0.90256875 |
| 76 | MP0003690_abnormal_glial_cell | 0.88332737 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.85958895 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.81440249 |
| 79 | MP0000313_abnormal_cell_death | 0.80560143 |
| 80 | MP0005390_skeleton_phenotype | 0.77700875 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.77317716 |
| 82 | MP0009764_decreased_sensitivity_to | 0.76107204 |
| 83 | MP0005164_abnormal_response_to | 0.75557342 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.73471921 |
| 85 | MP0003943_abnormal_hepatobiliary_system | 0.70199055 |
| 86 | MP0009763_increased_sensitivity_to | 0.70101097 |
| 87 | MP0008004_abnormal_stomach_pH | 0.68305097 |
| 88 | MP0001663_abnormal_digestive_system | 0.66120798 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.65640260 |
| 90 | MP0000477_abnormal_intestine_morphology | 0.64968123 |
| 91 | MP0001851_eye_inflammation | 0.63758385 |
| 92 | MP0002928_abnormal_bile_duct | 0.62961435 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.60780561 |
| 94 | MP0008874_decreased_physiological_sensi | 0.60139058 |
| 95 | MP0004381_abnormal_hair_follicle | 0.59354017 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.57177053 |
| 97 | MP0003045_fibrosis | 0.55546949 |
| 98 | MP0004130_abnormal_muscle_cell | 0.55237483 |
| 99 | MP0000343_altered_response_to | 0.54636182 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.54569397 |
| 101 | MP0003786_premature_aging | 0.53804522 |
| 102 | MP0005083_abnormal_biliary_tract | 0.53752336 |
| 103 | MP0002009_preneoplasia | 0.53029771 |
| 104 | MP0000350_abnormal_cell_proliferation | 0.52447118 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.51331878 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.50427225 |
| 107 | MP0008873_increased_physiological_sensi | 0.50363024 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.50048907 |
| 109 | MP0005023_abnormal_wound_healing | 0.49963195 |
| 110 | MP0000604_amyloidosis | 0.49579457 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.48914232 |
| 112 | MP0003828_pulmonary_edema | 0.47184915 |
| 113 | MP0003795_abnormal_bone_structure | 0.44757027 |
| 114 | MP0003279_aneurysm | 0.44450402 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.44100460 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.43786573 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.42712673 |
| 118 | MP0000249_abnormal_blood_vessel | 0.41646903 |
| 119 | MP0000598_abnormal_liver_morphology | 0.41529751 |
| 120 | MP0000371_diluted_coat_color | 0.41365732 |
| 121 | MP0000609_abnormal_liver_physiology | 0.39661126 |
| 122 | MP0004147_increased_porphyrin_level | 0.39380248 |
| 123 | MP0002083_premature_death | 0.38949034 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.38601861 |
| 125 | MP0000470_abnormal_stomach_morphology | 0.37408532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.56198252 |
| 2 | Recurrent bronchitis (HP:0002837) | 5.11313882 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.92704722 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.73054295 |
| 5 | Chronic otitis media (HP:0000389) | 4.66336612 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.43208603 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.41461571 |
| 8 | T lymphocytopenia (HP:0005403) | 4.36731004 |
| 9 | Agammaglobulinemia (HP:0004432) | 4.23680834 |
| 10 | Abnormality of T cells (HP:0002843) | 4.22850173 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.18253944 |
| 12 | Recurrent viral infections (HP:0004429) | 4.11005140 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.98712513 |
| 14 | Myositis (HP:0100614) | 3.98491108 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.98481710 |
| 16 | B lymphocytopenia (HP:0010976) | 3.90325711 |
| 17 | Abnormality of B cell number (HP:0010975) | 3.90325711 |
| 18 | Recurrent abscess formation (HP:0002722) | 3.87784097 |
| 19 | Abnormality of T cell physiology (HP:0011840) | 3.87661851 |
| 20 | Nasal polyposis (HP:0100582) | 3.87147557 |
| 21 | Thrombocytosis (HP:0001894) | 3.82055048 |
| 22 | Abnormality of the nasal mucosa (HP:0000433) | 3.73157694 |
| 23 | Hypochromic microcytic anemia (HP:0004840) | 3.72966723 |
| 24 | Hypochromic anemia (HP:0001931) | 3.71210941 |
| 25 | Meningitis (HP:0001287) | 3.70149524 |
| 26 | IgG deficiency (HP:0004315) | 3.65330210 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.64822186 |
| 28 | Urticaria (HP:0001025) | 3.59150209 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.51909848 |
| 30 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50084224 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50084224 |
| 32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.50081790 |
| 33 | Lymphopenia (HP:0001888) | 3.49770294 |
| 34 | Abnormal number of erythroid precursors (HP:0012131) | 3.48983789 |
| 35 | Cellulitis (HP:0100658) | 3.38351343 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38306779 |
| 37 | Pustule (HP:0200039) | 3.37183334 |
| 38 | Inflammation of the large intestine (HP:0002037) | 3.36362311 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 3.36242783 |
| 40 | Gingivitis (HP:0000230) | 3.34094961 |
| 41 | Petechiae (HP:0000967) | 3.30565141 |
| 42 | Recurrent sinusitis (HP:0011108) | 3.29744323 |
| 43 | Severe combined immunodeficiency (HP:0004430) | 3.27071826 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 3.24030712 |
| 45 | Reticulocytopenia (HP:0001896) | 3.18158238 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 3.17224962 |
| 47 | Spontaneous hematomas (HP:0007420) | 3.15312330 |
| 48 | Combined immunodeficiency (HP:0005387) | 3.13336940 |
| 49 | Keratoconjunctivitis (HP:0001096) | 3.10657255 |
| 50 | Aplastic anemia (HP:0001915) | 2.98340236 |
| 51 | Chronic sinusitis (HP:0011109) | 2.97038481 |
| 52 | Episodic fever (HP:0001954) | 2.95890807 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.95424054 |
| 54 | Gastrointestinal stroma tumor (HP:0100723) | 2.93276047 |
| 55 | Stomatitis (HP:0010280) | 2.91479708 |
| 56 | Bronchitis (HP:0012387) | 2.90663224 |
| 57 | Epistaxis (HP:0000421) | 2.89834254 |
| 58 | Verrucae (HP:0200043) | 2.89702990 |
| 59 | Papilloma (HP:0012740) | 2.89702990 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.88723338 |
| 61 | Recurrent skin infections (HP:0001581) | 2.84827123 |
| 62 | Thyroiditis (HP:0100646) | 2.83964673 |
| 63 | Vasculitis (HP:0002633) | 2.82671201 |
| 64 | Lymphoma (HP:0002665) | 2.79535545 |
| 65 | Encephalitis (HP:0002383) | 2.75052923 |
| 66 | Colitis (HP:0002583) | 2.74030395 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73277582 |
| 68 | Obstructive lung disease (HP:0006536) | 2.73277582 |
| 69 | Abnormality of the fingertips (HP:0001211) | 2.65183074 |
| 70 | Granulocytopenia (HP:0001913) | 2.54359173 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.53770990 |
| 72 | Pulmonary embolism (HP:0002204) | 2.50915925 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.50368696 |
| 74 | Anorexia (HP:0002039) | 2.49701332 |
| 75 | Basal cell carcinoma (HP:0002671) | 2.47203289 |
| 76 | Leukocytosis (HP:0001974) | 2.44034384 |
| 77 | Eosinophilia (HP:0001880) | 2.41947126 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.41860474 |
| 79 | Abnormality of macrophages (HP:0004311) | 2.39388936 |
| 80 | Chronic diarrhea (HP:0002028) | 2.38952098 |
| 81 | Abnormality of the pleura (HP:0002103) | 2.38687777 |
| 82 | Pallor (HP:0000980) | 2.38131692 |
| 83 | IgA deficiency (HP:0002720) | 2.36074592 |
| 84 | Autoimmune hemolytic anemia (HP:0001890) | 2.35544618 |
| 85 | Increased IgE level (HP:0003212) | 2.33766371 |
| 86 | Hepatosplenomegaly (HP:0001433) | 2.33690401 |
| 87 | Arterial thrombosis (HP:0004420) | 2.32024851 |
| 88 | Neutropenia (HP:0001875) | 2.30041020 |
| 89 | Poikiloderma (HP:0001029) | 2.29999905 |
| 90 | Microcytic anemia (HP:0001935) | 2.26611490 |
| 91 | Hemoptysis (HP:0002105) | 2.25884780 |
| 92 | Optic neuritis (HP:0100653) | 2.23882567 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 2.23882567 |
| 94 | Increased serum ferritin (HP:0003281) | 2.21991427 |
| 95 | Orchitis (HP:0100796) | 2.19318530 |
| 96 | Acute hepatic failure (HP:0006554) | 2.17236800 |
| 97 | Recurrent otitis media (HP:0000403) | 2.15625960 |
| 98 | Emphysema (HP:0002097) | 2.14202929 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 2.13958093 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.12979604 |
| 101 | Gangrene (HP:0100758) | 2.12082290 |
| 102 | Purpura (HP:0000979) | 2.11466588 |
| 103 | Type I transferrin isoform profile (HP:0003642) | 2.10089733 |
| 104 | Abnormal platelet function (HP:0011869) | 2.09092393 |
| 105 | Impaired platelet aggregation (HP:0003540) | 2.09092393 |
| 106 | Recurrent pneumonia (HP:0006532) | 2.05541699 |
| 107 | Gingival bleeding (HP:0000225) | 2.04155546 |
| 108 | Chest pain (HP:0100749) | 2.03635598 |
| 109 | Osteomyelitis (HP:0002754) | 2.03535197 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.03474950 |
| 111 | Interstitial pulmonary disease (HP:0006530) | 2.02659772 |
| 112 | Abnormal platelet volume (HP:0011876) | 2.02614968 |
| 113 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02326992 |
| 114 | Restrictive lung disease (HP:0002091) | 2.01391698 |
| 115 | Muscle fiber atrophy (HP:0100295) | 2.00472879 |
| 116 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.99925597 |
| 117 | Increased IgM level (HP:0003496) | 1.99454658 |
| 118 | Skin rash (HP:0000988) | 1.98762345 |
| 119 | Glomerulopathy (HP:0100820) | 1.98623386 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98404502 |
| 121 | Skin ulcer (HP:0200042) | 1.97834849 |
| 122 | Peritonitis (HP:0002586) | 1.96733508 |
| 123 | Hypertensive crisis (HP:0100735) | 1.96655691 |
| 124 | Joint swelling (HP:0001386) | 1.95936362 |
| 125 | Sepsis (HP:0100806) | 1.94655719 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 1.93516575 |
| 127 | Abnormality of the pericardium (HP:0001697) | 1.91777693 |
| 128 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91531210 |
| 129 | Viral hepatitis (HP:0006562) | 1.90179605 |
| 130 | Slow saccadic eye movements (HP:0000514) | 1.87088868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.41949780 |
| 2 | TXK | 3.42321020 |
| 3 | EEF2K | 2.68091785 |
| 4 | ZAP70 | 2.65834593 |
| 5 | BLK | 2.54073882 |
| 6 | JAK3 | 2.53818424 |
| 7 | GRK6 | 2.42252350 |
| 8 | BTK | 2.31188227 |
| 9 | MAP3K10 | 2.29214404 |
| 10 | TEC | 2.22618718 |
| 11 | NME2 | 2.19497768 |
| 12 | PRPF4B | 2.19075008 |
| 13 | STK10 | 2.01749967 |
| 14 | TYK2 | 2.01129841 |
| 15 | KIT | 2.01018057 |
| 16 | ITK | 1.99198304 |
| 17 | IKBKE | 1.91574969 |
| 18 | KDR | 1.86833927 |
| 19 | TBK1 | 1.80567824 |
| 20 | IRAK4 | 1.80492771 |
| 21 | SYK | 1.79692451 |
| 22 | TGFBR2 | 1.74912435 |
| 23 | EPHB1 | 1.70848321 |
| 24 | TAOK1 | 1.70533780 |
| 25 | NLK | 1.62553264 |
| 26 | TGFBR1 | 1.62415614 |
| 27 | MAP3K3 | 1.58634503 |
| 28 | LRRK2 | 1.53500202 |
| 29 | LCK | 1.52115592 |
| 30 | CSF1R | 1.51646339 |
| 31 | FLT3 | 1.40985225 |
| 32 | MAP3K14 | 1.34941177 |
| 33 | TNK2 | 1.28662121 |
| 34 | IKBKB | 1.28535225 |
| 35 | FGR | 1.27762621 |
| 36 | STK16 | 1.25013896 |
| 37 | MAP2K3 | 1.22184388 |
| 38 | RPS6KA4 | 1.22134073 |
| 39 | JAK1 | 1.21384963 |
| 40 | CLK1 | 1.20055210 |
| 41 | ACVR1B | 1.19743821 |
| 42 | FGFR4 | 1.18983060 |
| 43 | FES | 1.18091346 |
| 44 | MAP3K1 | 1.17169737 |
| 45 | PIM1 | 1.12727849 |
| 46 | LYN | 1.12364703 |
| 47 | HCK | 1.10801278 |
| 48 | CSK | 1.07909982 |
| 49 | BMPR2 | 1.06706734 |
| 50 | SMG1 | 1.04412073 |
| 51 | MAP3K13 | 1.01157844 |
| 52 | RPS6KB2 | 1.00865714 |
| 53 | NEK2 | 0.95390172 |
| 54 | ERN1 | 0.93885581 |
| 55 | TAOK2 | 0.91632418 |
| 56 | TESK2 | 0.88843377 |
| 57 | IRAK3 | 0.88548240 |
| 58 | MARK2 | 0.88382706 |
| 59 | MARK3 | 0.88222037 |
| 60 | PKN2 | 0.86994273 |
| 61 | PASK | 0.82644809 |
| 62 | TNIK | 0.82052264 |
| 63 | WEE1 | 0.81927743 |
| 64 | DYRK3 | 0.81907631 |
| 65 | MAP2K6 | 0.79358371 |
| 66 | YES1 | 0.77140770 |
| 67 | SIK2 | 0.76129127 |
| 68 | FYN | 0.75788228 |
| 69 | FGFR3 | 0.75685713 |
| 70 | TLK1 | 0.75291252 |
| 71 | PIM2 | 0.73783279 |
| 72 | KSR2 | 0.72705516 |
| 73 | TRIB3 | 0.72390644 |
| 74 | MAP3K12 | 0.70596045 |
| 75 | CDK4 | 0.70122197 |
| 76 | PTK6 | 0.69211057 |
| 77 | SIK3 | 0.68068170 |
| 78 | CDC7 | 0.65430467 |
| 79 | EIF2AK3 | 0.65373522 |
| 80 | CDK19 | 0.64594306 |
| 81 | SCYL2 | 0.63998446 |
| 82 | ADRBK2 | 0.63106906 |
| 83 | MST4 | 0.62836671 |
| 84 | TAOK3 | 0.62247691 |
| 85 | MAP3K7 | 0.62066235 |
| 86 | PDPK1 | 0.61220153 |
| 87 | CAMKK1 | 0.60672373 |
| 88 | EIF2AK1 | 0.60649849 |
| 89 | BRSK2 | 0.60457479 |
| 90 | HIPK2 | 0.58465937 |
| 91 | STK4 | 0.58302025 |
| 92 | PRKCQ | 0.58149526 |
| 93 | JAK2 | 0.57587343 |
| 94 | STK11 | 0.57116421 |
| 95 | MAPK11 | 0.55991504 |
| 96 | ATR | 0.54835198 |
| 97 | PRKCH | 0.53772437 |
| 98 | VRK1 | 0.53306559 |
| 99 | DYRK1B | 0.52236211 |
| 100 | STK38 | 0.52126022 |
| 101 | RIPK4 | 0.51757407 |
| 102 | MAPK7 | 0.49179541 |
| 103 | PTK2B | 0.48542060 |
| 104 | IRAK1 | 0.47193995 |
| 105 | IRAK2 | 0.47063054 |
| 106 | MAPK4 | 0.46974584 |
| 107 | PRKD2 | 0.46812443 |
| 108 | CHUK | 0.46719676 |
| 109 | MAP3K6 | 0.46408324 |
| 110 | CDK7 | 0.46156880 |
| 111 | SIK1 | 0.45879687 |
| 112 | RPS6KA6 | 0.44722360 |
| 113 | RET | 0.44244671 |
| 114 | MAP3K5 | 0.43848997 |
| 115 | MAPKAPK2 | 0.43674571 |
| 116 | MAPKAPK3 | 0.43530399 |
| 117 | TRPM7 | 0.40159072 |
| 118 | PIK3CG | 0.39197070 |
| 119 | RAF1 | 0.38718866 |
| 120 | MAP3K11 | 0.36423001 |
| 121 | MAPK12 | 0.36087387 |
| 122 | STK24 | 0.35967766 |
| 123 | CDC42BPA | 0.34911708 |
| 124 | PRKG2 | 0.33659085 |
| 125 | CAMKK2 | 0.33122771 |
| 126 | SRPK1 | 0.32601088 |
| 127 | RPS6KC1 | 0.31620656 |
| 128 | RPS6KL1 | 0.31620656 |
| 129 | MAP3K8 | 0.30943332 |
| 130 | MATK | 0.29215735 |
| 131 | PRKCD | 0.29170628 |
| 132 | PDK1 | 0.28852847 |
| 133 | MAP2K4 | 0.28583467 |
| 134 | PRKD1 | 0.27916727 |
| 135 | BRSK1 | 0.26786258 |
| 136 | MAP2K2 | 0.25100921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.94537389 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.29886314 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.83139591 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44493061 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40992021 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.40132753 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.38506342 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34187609 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.33211187 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23317083 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16940270 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16112246 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12129975 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 2.11705054 |
| 15 | Base excision repair_Homo sapiens_hsa03410 | 2.06074745 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05914994 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77862704 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72895931 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65701408 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54868845 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.54810407 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51885573 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.51751484 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.47829779 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38710806 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35326228 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31472017 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30280192 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.30074259 |
| 30 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.29598968 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24329621 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.22288090 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21546659 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.15019500 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12497642 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12188239 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.10557089 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.08660397 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.08246381 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.07434554 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06638063 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06301836 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05754987 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.05583338 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.04947708 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.04694085 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.02633302 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02010299 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00226724 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.00108287 |
| 51 | Proteasome_Homo sapiens_hsa03050 | 0.99698884 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96851506 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94461427 |
| 54 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90757584 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.90708352 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90429432 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89179390 |
| 58 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88543563 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87528902 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86824486 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84070050 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.83878693 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83594356 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.81590425 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81223657 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80317566 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78571863 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.76716131 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.74858417 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70458021 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70454111 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69925216 |
| 73 | Malaria_Homo sapiens_hsa05144 | 0.69220959 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.67763281 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67583174 |
| 76 | RNA transport_Homo sapiens_hsa03013 | 0.67089413 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.65228218 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64651005 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63938925 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63933886 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63682213 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63359906 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62819206 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61735718 |
| 85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.61432832 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59697952 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58861027 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58531196 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55520610 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54130021 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53650820 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53338181 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53240794 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53214775 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.53151571 |
| 96 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52804504 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52180515 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51665527 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51308425 |
| 100 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50206856 |
| 101 | Protein export_Homo sapiens_hsa03060 | 0.49453142 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49153559 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49111064 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48777532 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48607355 |
| 106 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48479547 |
| 107 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46867041 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46022124 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45701770 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45280476 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44488175 |
| 112 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44426434 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43321087 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41241746 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.39799731 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39714496 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39257495 |
| 118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.36208679 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35168656 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34582804 |
| 121 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34198810 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.33818430 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33283315 |
| 124 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33006871 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.32805772 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31227585 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30968234 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30366028 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27589987 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.26078812 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24767105 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24452604 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22416534 |

